StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
9605.SR$2.80+3.32%
Fair $2.80+0.0%

9605.SR

9605.SR

Basic Materials / Specialty ChemicalsSaudi

$2.80

+0.09 (+3.32%)

Fairly Valued+0.0%Fair Value $2.80Fund rank 27/100 · Data gapFallback financials|
SA 29/D
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 20%

FCF escenarios

weak_data · normalized FCF $-9.3M · quality 51.7/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 26/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

29/100

D

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

12/100

SEC 0%

Latest source: unknownPeriods: 3Warnings: 1unknown: 3
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -3.7%, below the 5% threshold
Thesis & Journal · 9605.SRLocal privado en este navegador · 9605.SR
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$70M

P/E

N/A

•

EV/EBITDA

24.3x

↑

ROE

-3.7%

↓

Gross Margin

17.4%

↓

Debt/Equity

0.43

↑
52-Week Range$3
$2$5

TradingView lightweight chart

9605.SR price, volumen y niveles de valoración

Último $2.800Periodo -32.0%
Fair value: $2.800

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2025 · 2 años de histórico normalizado

Revenue CAGR

+9.1%

FCF CAGR

—

FCF margin

-20.2%

FCF / Net income

8.61x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $73.8M · net income $-1.7M · FCF $-14.9M

2023-FY → 2025-FY

Gross margin

17.4%+1.2% pts

Operating margin

-0.9%-9.3% pts

Net margin

-2.3%-9.4% pts

FCF margin

-20.2%-21.6% pts
MetricTTM
2025
2024
2023
Income Statement
Revenue$73.8M$73.8M$62.8M$62.0M
Net Income$-1.7M$-1.7M$2.6M$4.4M
EBITDA$3.4M$3.4M$5.7M$6.5M
EPS——0.110.18
Gross Margin17.4%17.4%18.5%16.2%
Operating Margin-0.9%-0.9%6.1%8.4%
Net Margin-2.3%-2.3%4.2%7.1%
Balance Sheet
Debt/Equity0.430.430.22—
Current Ratio2.842.84——
Cash Flow
Free Cash Flow$-14.9M$-14.9M$-9.3M$864326.00
Returns
ROE-3.7%-3.7%5.5%15.5%
Valuation
P/E——43.64—
EV/EBITDA24.3424.3419.03—
P/B1.511.512.30—
Growth & Yield
Revenue Growth17.6%17.6%1.2%—
EPS Growth——-37.4%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -30.7%

Total return

-30.7%

Start / end P/E

n/dx → n/dx

EPS bridge

0.11 → n/d

Residual

-30.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-30.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.